- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06336265
Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High-flow Nasal Cannula Oxygen Therapy
March 26, 2024 updated by: Xingui Dai
Clinical Study of Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High Flow Oxygen Therapy in Mild and Moderate Acute Hypoxic Respiratory Failure
Follow-up was conducted for every patient requiring high-flow nasal cannula oxygen therapy in district 1 of the Intensive Care Department of Chenzhou NO.1 People's Hospital.
Patients who met the inclusion criteria but did not meet the exclusion criteria were included for observation.
Respiratory parameters, diaphragmatic activity, and variation rate of diaphragmatic thickness were recorded at the beginning of high-flow nasal cannula oxygen therapy, 1 hour after treatment, 3 hours after treatment, 6 hours after treatment, 9 hours after treatment, and 12 hours after treatment.
Throughout the procedure, a panel of experts assessed whether the patient needed endotracheal intubation; If yes, the study was terminated; if no, high-flow nasal cannula oxygen therapy was continued, and observation and evaluation were continued until the end point of the study (12 hours after treatment).
If patients or their family members do not want to continue to participate in the study during the study, they will be considered as withdrawal.
If patients suffer from sudden malignant arrhythmia or cardiac arrest during the study, resulting in death or transfer to other hospitals or other departments during the study, patients will be excluded.
Data from dropped and excluded patients were not included in the final statistical analysis.
After the data of 269 patients were collected, the study was concluded, and the results and conclusions were derived by statistical analysis.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
269
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Feng Yang, Master
- Phone Number: 15886524007
- Email: 17546639@qq.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with mild to moderate hypoxic respiratory failure who are over 18 years old and less than 75 years old and who do not have serious cardiopulmonary disease, malnutrition, or respiratory obstruction and require high-flow nasal cannula oxygen therapy
Description
Inclusion Criteria:
- Age ≥18 years old, less than 75 years old,BMI≥18.5kg/m2
- Mild to moderate type I respiratory failure (100mmHg< PaO2/FiO2≤300mmHg)
- Mild ventilation dysfunction (pH≥7.3)
- Mild respiratory distress (respiratory rate > 24 times/min)
- High-flow nasal cannula oxygen therapy is required
- The patient and immediate family members agree and sign a written informed consent.
Exclusion Criteria:
- Patients with severe type II respiratory failure, severe asthma and massive hemoptysis
- Moderate to severe consciousness disorder, GCS score ≤12 points
- Cardiogenic pulmonary edema and cardiogenic dyspnea caused by heart failure, heart valvular disease, myocarditis, etc
- Hemodynamic instability, SBP< 90mmHg, or MAP<65mmHg
- BMI < 18.5kg/m2
- Nasal bleeding, nasal space occupying lesions, etc., can not be high-flow nasal cannula oxygen therapy through the nose or nasal obstruction
- Patients with severe hypoxemia, severe ARDS and other conditions requiring immediate tracheal intubation
- The patient or family member refuses to participate or does not agree to sign the written informed consent
- The patient has participated in other research projects with interventions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thickness and thickening fraction of Diaphragm
Time Frame: 0-12 hours
|
Diaphragm thickness and thickening fraction (TFdi) were measured using a high-frequency linear array probe at the midaxillary line.
TFdi = (diaphragm thickness at the end of inspirations - diaphragm thickness at the end of expirations)/diaphragm thickness at the end of expirations × 100%
|
0-12 hours
|
Diaphragmatic excursion
Time Frame: 0-12 hours
|
Diaphragmatic excursion was measured using a low-frequency curved array (" abdomen ") probe located directly below the costal arch on the midline of the clavicle.
|
0-12 hours
|
Respiratory rate
Time Frame: 0-12 hours
|
Respiratory rate of the patient after high-flow nasal oxygen therapy
|
0-12 hours
|
Incidence of tracheal intubation
Time Frame: 0-12 hours
|
After the patient uses high-flow nasal oxygen therapy, the panel determine whether the patient needs to undergo tracheal intubation according to the indicators such as symptoms and signs of the patient.
|
0-12 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2024
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
March 13, 2024
First Submitted That Met QC Criteria
March 26, 2024
First Posted (Actual)
March 28, 2024
Study Record Updates
Last Update Posted (Actual)
March 28, 2024
Last Update Submitted That Met QC Criteria
March 26, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Diaphragm ultrasound
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoxic Respiratory Failure
-
University Hospital Bispebjerg and FrederiksbergNot yet recruitingHypoxic Respiratory Failure | Ventilators, MechanicalDenmark
-
Azienda Ospedaliero Universitaria Maggiore della...CompletedAcute Hypoxic - Hypercapnic Respiratory Failure (ARF)Italy
-
Nationwide Children's HospitalWithdrawnHypoxic Respiratory Failure | PPHN
-
University of PadovaCompleted
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingCorona Virus Infection | Hypoxic Respiratory FailureChina
-
Johns Hopkins UniversityTerminatedCOVID | Hypoxic Respiratory FailureUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Institute of Mountain Emergency MedicineMedical University InnsbruckCompletedHypercapnic Respiratory Failure | Hypoxic Respiratory Failure | Avalanche Burial | Snow Physical PropertiesItaly
-
Medical University of ViennaUnknownAcute Liver Failure | Hypoxic Hepatitis | Ischemic Hepatitis | Shock Liver | Hypoxic Liver InjuryGermany, Austria
-
MallinckrodtWithdrawnHypoxic Respiratory Failure With Pulmonary Hypertension
Clinical Trials on Diaphragm ultrasound
-
Università Vita-Salute San RaffaeleCompleted
-
Leiden University Medical CenterRecruitingUltrasound | Diaphragm | Neonate | Transcutaneous EMGNetherlands
-
Zagazig UniversityCompleted
-
Queen Mary Hospital, Hong KongRecruitingAcute Hypoxemic Respiratory FailureHong Kong
-
Corporacion Parc TauliWithdrawnWeaning | Diaphragm Ultrasound | Maximum Inspiratory PressureSpain
-
Albert Einstein Healthcare NetworkTerminatedMechanical Ventilation ComplicationUnited States
-
Fondation Hôpital Saint-JosephCentre Hospitalier Universitaire Dijon; St Vincent's Hospital, Sydney; Hopital...Active, not recruitingCritical Illness | Respiratory DiseaseFrance, Australia
-
Karolinska University HospitalKarolinska InstitutetNot yet recruitingPneumonia | Respiratory Insufficiency | Desaturation of Blood | Tachypnea | Atelectasis, PostoperativeSweden
-
Mongi Slim HospitalRecruitingMechanical Ventilation WeaningTunisia
-
IsalaRecruiting